Low vitamin B6 levels and the risk of recurrent venous thromboembolism

Haematologica

Volumn 92, Issue 9, 2007, Pages 1250-1253

  Hron, Gregor ^b   Lombardi, Rossana ^a   Eichinger, Sabine ^b   Lecchi, Anna ^a   Kyrie, Paul A ^b   Cattaneo, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Deep vein thrombosis; Homocysteine; Pulmonary embolism; Risk factors; Vitamin B6

Indexed keywords

PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE;

ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RISK; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ADOLESCENT; COHORT STUDIES; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS; VITAMIN B 6 DEFICIENCY;

EID: 36348999233     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11318     Document Type: Article

References (20)

1. Yap S, Boers GH, Wilcken B, Wilcken DE, Brenton DP, Lee PJ, et al. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol. 2001;21:2080-5.
2. den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005;3:292-9.
3. Eichinger S, Stumpften A, Hirschl M, Bialonczyk C, Herkner K, Stain M, et al. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost 1998; 80:566-9.
4. Cattaneo M. Hyperhomocysteinemia and venous thromboembolism. Semin Thromb Hemost 2006;32:716-23.
5. den Heijer M, Willems HP, Blom HJ, Gerrits WB, Cattaneo M, Eichinser S, et al. Homocysteine lowering by B vitamins and the secondary prevention of deep-vein thrombosis and pulmonary embolism. A randomized, placebo-controlled, double blind trial. Blood 2007;109:139-44.
6. Quere I, Perneger TV, Zittoun J, Bellet H, Gris JC, Daures JP, et al. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet. 2002-359:747-52.
7. Diaz DE, Tuesta AM, Ribo MD, Belinchon O, Marchena PJ, Bruscas MJ, et al. Low levels of vitamin B12 and venous thromboembolic disease in elderly men. J Intern Med 2005; 258:244-9.
8. Oger E, Lacut K, Le Gal G, Couturaud F, Guénet D, Abalain J-H, et al. Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost 2006;4:793-9.
9. Cattaneo M, Lombardi R, Lecchi A, Bucciarelli P, Mannucci PM. Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis. Circulation. 2001;104:2442-6.
10. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004;350:2558-63.
11. Shin-Buehring Y, Rasshofer R, Endres W. A new enzymatic method for pyridoxal-5′-phosphate determination. J Inherit Metab Dis 1981; 4:123-4.
12. Bender DA. Novel functions of vitamin B6. Proc Nutr Soc 1994;53:625-30.
13. van Wyk V, Luus HG, Heyns AD. The in vivo effect in humans of pyridoxal-5′-phosphate on platelet function and blood coagulation. Thromb Res 1992;66:657-68.
14. Friso S, Jacques PF, Wilson PW, Rosenberg IH, Selhub J. Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation 2001;103:2788-91.
15. Saibeni S, Cattaneo M, Vecchi M, Zighetti ML, Lecchi A, Lombardi R, et al. Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 2003;98:112-7.
16. Chiang EP, Bagley PJ, Selhub J, Nadeau M, Roubenoff R. Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med 2003; 114:283-7.
17. Cattaneo M, Lombardi R, Lecchi A, Bos G, Blom H, Rosendaal FR, et al. Low plasma levels of vitamin B6 and recurrent venous thrombosis: risk assessment and effect of combined vitamin supplementation in the VITRO-trial. J Thromb Haemost 2005;3:P1079.
18. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-75.
19. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354:1578-88.
20. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567-77.